Beware, women smokers! If health warnings are not enough to put you off the habit, just give a second thought before you puff your next fag because smoking can also cause spots.
A previously unknown side effect of an unnamed drug currently on the marketplace could be useful for treating acne, reports Chemistry & Industry, the magazine of the SCI.
While laser and light-based therapies continue to make their mark on many dermatologic procedures, some dermatologists believe the tried-and-true oral medications for treating moderate to severe acne offer patients the best long-term treatment outcomes. In fact, the introduction of new oral acne medications demonstrates that the demand for systemic acne therapies is still strong.
Doctors can describe the symptoms of rosacea, a common inflammatory skin disease that causes facial redness and affects nearly 14 million Americans. They can tell patients what triggers can worsen their condition: spicy foods, heat, alcohol, even embarrassment. But until now, they could not explain what caused rosacea.
The appearance of a rash in cancer patients treated with erlotinib (Tarceva) is strongly associated with longer survival, according to researchers from the drug?s developer, OSI Pharmaceuticals, Inc.
Skin reactions to a powerful new class of anti-cancer drugs are frequent, but manageable through a simple and rational treatment approach — usually without the need to reduce the dose or interrupt treatment with potentially life-prolonging chemotherapy, according to an article in the May issue of “The Oncologist.”
The Skin Research Centre at the University of Leeds (UK), which has led the way in the treatment of acne, eczema and other skin conditions, is the only University skin microbiology laboratory in the UK to receive the international quality standard ISO 17025.
Ob-gyns addressed the critical need for increased insurance coverage of contraceptive services for women in the US at a news conference during the 55th Annual Clinical Meeting of The American College of Obstetricians and Gynecologists (ACOG).
Bayer HealthCare Pharmaceuticals Inc, a U.S.-based pharmaceuticals unit of Bayer HealthCare., and Intendis Inc., a U.S.-based affiliate of Bayer Schering Pharma AG, Germany, announced today that they will jointly promote YAZ? (drospirenone/ethinyl estradiol) as a treatment for moderate acne in women who desire an oral contraceptive for birth control. The agreement came into effect on May 1, as part of an overall strategy to introduce dermatologists to the anti-acne benefits of YAZ.
Scientists have discovered one of the reasons why bladder cancer is so much more prevalent in men than women: A molecular receptor or protein that is much more active in men than women plays a role in the development of the disease. The finding could open the door to new types of treatment with the disease.